MedCap AB (publ) (STO:MCAP)

Revenue by Geography

Financials in millions SEK. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2017	FY 2016
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Apr 30, 2017	Apr 30, 2016
Sweden Revenue	957.30M	898.40M
Sweden Revenue Growth	6.56%	11.99%
Nordic (ex-Sweden) Revenue	612.50M	448.60M
Nordic (ex-Sweden) Revenue Growth	36.54%	30.14%
Europe (ex-Nordic) Revenue	484.60M	384.70M
Europe (ex-Nordic) Revenue Growth	25.97%	-2.46%
Rest of the World Revenue	53.70M	75.10M
Rest of the World Revenue Growth	-28.49%	63.26%

Revenue Breakdown

Financials in millions SEK. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2017	FY 2016
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Apr 30, 2017	Apr 30, 2016
Assistive Tech Revenue	981.80M	767.20M
Assistive Tech Revenue Growth	27.97%	29.92%
Medtech Revenue (Post-Q2 2023 Reporting)	689.60M	607.70M
Medtech Revenue (Post-Q2 2023 Reporting) Growth	13.48%	18.76%
Medtech Revenue (Pre-Q3 2023 Reporting)	1.67B	1.37B
Medtech Revenue (Pre-Q3 2023 Reporting) Growth	21.57%	24.75%
Specialty Pharma Revenue	436.60M	431.80M
Specialty Pharma Revenue Growth	1.11%	-11.02%

Revenue Breakdown 2

Financials in millions SEK. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2017	FY 2016
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Apr 30, 2017	Apr 30, 2016
Pharmaceuticals Revenue	424.80M	420.50M
Pharmaceuticals Revenue Growth	1.02%	-13.64%
Assistive Technology Revenue	981.30M	765.90M
Assistive Technology Revenue Growth	28.12%	30.17%
Medical Devices Revenue	320.10M	322.70M
Medical Devices Revenue Growth	-0.81%	25.86%
Nutrition & Other Food Revenue	333.60M	251.80M
Nutrition & Other Food Revenue Growth	32.49%	13.37%
Other Product Revenue	48.20M	45.90M
Other Product Revenue Growth	5.01%	36.61%

Adjusted EBITDA

Financials in millions SEK. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2017	FY 2016
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Apr 30, 2017	Apr 30, 2016
Assistive Tech Adjusted EBITDA	289.50M	212.00M
Assistive Tech Adjusted EBITDA Growth	36.56%	45.20%
Medtech Adjusted EBITDA (Post-Q2 2023 Reporting)	145.90M	138.30M
Medtech Adjusted EBITDA (Post-Q2 2023 Reporting) Growth	5.50%	39.70%
Medtech Adjusted EBITDA (Pre-Q3 2023 Reporting)	435.40M	350.30M
Medtech Adjusted EBITDA (Pre-Q3 2023 Reporting) Growth	24.29%	42.98%
Specialty Pharma Adjusted EBITDA	45.70M	59.20M
Specialty Pharma Adjusted EBITDA Growth	-22.80%	-46.18%
Other and Eliminations from Adjusted EBITDA	-24.80M	-21.70M

EBIT

Financials in millions SEK. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2017	FY 2016
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Apr 30, 2017	Apr 30, 2016
Assistive Tech Operating Profit	217.30M	164.10M
Assistive Tech Operating Profit Growth	32.42%	50.55%
Medtech Operating Profit (Post-Q2 2023 Reporting)	103.20M	98.70M
Medtech Operating Profit (Post-Q2 2023 Reporting) Growth	4.56%	53.02%
Medtech Operating Profit (Pre-Q3 2023 Reporting)	320.50M	262.80M
Medtech Operating Profit (Pre-Q3 2023 Reporting) Growth	21.96%	51.47%
Specialty Pharma Operating Profit	9.20M	33.40M
Specialty Pharma Operating Profit Growth	-72.45%	-59.27%
Other and Eliminations from Operating Profit	-26.80M	-23.90M

Updated Dec 31, 2025. Data Source: Fiscal.ai.